NK Cell Therapies Pipeline Report 2024: Insights on 80+ Companies and 100+ Pipeline Drugs, Including ALECSAT (CytoVac), NKTR-214/Bempegaldesleukin (Nektar Therapeutics), and Monalizumab (Innate Pharma)
April 26, 2024 04:12 ET
|
Research and Markets
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "NK Cell Therapies - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Global Natural Killer Cells Therapeutics Research Report 2023: Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2022 and 2023-2028
January 03, 2024 11:33 ET
|
Research and Markets
Dublin, Jan. 03, 2024 (GLOBE NEWSWIRE) -- The "Global Natural Killer Cells Therapeutics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Anti-CD38 Antibody Pipeline Research Report 2023 Featuring Sorrento Therapeutics, I-MAB Biopharma, Takeda, Hangzhou Sumgen Biotech, Wuhan YZY Biopharma, and Biomunex Pharmaceuticals
November 22, 2023 08:38 ET
|
Research and Markets
Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "Anti-CD38 antibody - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Natural Killer Cells Therapeutics Market Analysis and Industry Forecast to 2027: Advancements in Manufacturing Processes, Cell Engineering Techniques and Development of Combination Therapies
August 07, 2023 06:03 ET
|
Research and Markets
Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "Natural Killer Cells Therapeutics Market by Therapeutics, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2027" report...
Elotuzumab Emerging Drug Insight and Market Forecast 2022-2032: Comprehensive Analysis on Drug Mechanisms, R&D Activities, Key Players and Emerging Therapies
February 16, 2023 11:13 ET
|
Research and Markets
Dublin, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The "Elotuzumab Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides...
Natural Killer Cells Therapeutics Global Market Report 2022: Rise in Awareness about Immunotherapies Bolsters Sector
December 09, 2022 05:33 ET
|
Research and Markets
Dublin, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The "Natural Killer Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Type (Natural Killer...
2022 Outlook on the Anti TIGIT Antibody Global Market: By Phase, Company, Country and Indication
December 05, 2022 06:33 ET
|
Research and Markets
Dublin, Dec. 05, 2022 (GLOBE NEWSWIRE) -- The "Global Anti TIGIT Antibody Clinical Trials & Companies Insight 2023" report has been added to ResearchAndMarkets.com's offering. This report...
Natural Killer (NK) Cell Therapeutics Market Research Report 2022
August 09, 2022 06:08 ET
|
Research and Markets
Dublin, Aug. 09, 2022 (GLOBE NEWSWIRE) -- The "Natural Killer (NK) Cell Therapeutics Market - A Global and Regional Analysis: Focus on NK Cell Therapy Type, Indication, Country, Pipeline Analysis,...
Insights on the Natural Killer Cells Therapeutics Global Market to 2027 - by Therapeutics, Application, End-user and Region
July 01, 2022 07:13 ET
|
Research and Markets
Dublin, July 01, 2022 (GLOBE NEWSWIRE) -- The "Natural Killer Cells Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Global Cellular Immunotherapy Market (2022 to 2031) - Featuring Novartis, Gilead Sciences and Dendreon Pharmaceuticals Among Others
March 22, 2022 05:18 ET
|
Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Cellular Immunotherapy Global Market Report 2022: By Therapy, By Primary, By Application" report has been added to ResearchAndMarkets.com's offering....